Negative Feed-forward Control of Tumor Necrosis Factor (TNF) by Tristetraprolin (ZFP36) Is Limited by the Mitogen-activated Protein Kinase Phosphatase, Dual-specificity Phosphatase 1 (DUSP1): IMPLICATIONS FOR REGULATION BY GLUCOCORTICOIDS

J Biol Chem. 2016 Jan 1;291(1):110-25. doi: 10.1074/jbc.M115.697599. Epub 2015 Nov 6.

Abstract

TNF is central to inflammation and may play a role in the pathogenesis of asthma. The 3'-untranslated region of the TNF transcript contains AU-rich elements (AREs) that are targeted by the RNA-binding protein, tristetraprolin (also known as zinc finger protein 36 (ZFP36)), which is itself up-regulated by inflammatory stimuli, to promote mRNA degradation. Using primary human bronchial epithelial and pulmonary epithelial A549 cells, we confirm that interleukin-1β (IL1B) induces expression of dual-specificity phosphatase 1 (DUSP1), ZFP36, and TNF. Whereas IL1B-induced DUSP1 is involved in feedback control of MAPK pathways, ZFP36 exerts negative (incoherent) feed-forward control of TNF mRNA and protein expression. DUSP1 silencing increased IL1B-induced ZFP36 expression at 2 h and profoundly repressed TNF mRNA at 6 h. This was partly due to increased TNF mRNA degradation, an effect that was reduced by ZFP36 silencing. This confirms a regulatory network, whereby DUSP1-dependent negative feedback control reduces feed-forward control by ZFP36. Conversely, whereas DUSP1 overexpression and inhibition of MAPKs prevented IL1B-induced expression of ZFP36, this was associated with increased TNF mRNA expression at 6 h, an effect that was predominantly due to elevated transcription. This points to MAPK-dependent feed-forward control of TNF involving ZFP36-dependent and -independent mechanisms. In terms of repression by dexamethasone, neither silencing of DUSP1, silencing of ZFP36, nor silencing of both together prevented the repression of IL1B-induced TNF expression, thereby demonstrating the need for further repressive mechanisms by anti-inflammatory glucocorticoids. In summary, these data illustrate why understanding the competing effects of feedback and feed-forward control is relevant to the development of novel anti-inflammatory therapies.

Keywords: DUSP1; anti-inflammatory; dual-specificity phosphoprotein phosphatase; feed-forward control; glucocorticoid; inflammation; mitogen-activated protein kinase (MAPK); tumor necrosis factor (TNF).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Dexamethasone / pharmacology
  • Dual Specificity Phosphatase 1 / metabolism*
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism
  • Gene Expression Regulation / drug effects
  • Gene Knockdown Techniques
  • Gene Silencing / drug effects
  • Glucocorticoids / pharmacology*
  • Humans
  • Inflammation / genetics
  • Interleukin-1beta / pharmacology
  • Protein Kinase Inhibitors / pharmacology
  • Small Molecule Libraries / pharmacology
  • Tristetraprolin / genetics
  • Tristetraprolin / metabolism*
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Glucocorticoids
  • Interleukin-1beta
  • Protein Kinase Inhibitors
  • Small Molecule Libraries
  • Tristetraprolin
  • Tumor Necrosis Factor-alpha
  • Dexamethasone
  • DUSP1 protein, human
  • Dual Specificity Phosphatase 1